MSDH: available COVID-19 treatments are being underutilized in the state
Published 5:12 pm Friday, February 11, 2022
Treatment is available for those who get COVID-19, but treatments are being underutilized, State Health Officer Dr. Thomas Dobbs said Friday during a press conference held by the Mississippi State Department of Health.
Dobbs said although the numbers of COVID cases are going down and there is a decline in hospitalizations, MSDH is still recording thousands of cases every day.
“And we will continue to see more illness and deaths,” he said.
Email newsletter signup
However, with a “new generation” of treatments, Dobbs said, outcomes for those who contract the virus could improve, “and we want people to know about these treatments and how to access them,” he said.
Paxlovid and Molnupiravir are two oral antiviral medications that have been successful for the Omicron variant, Dobbs reported.
“Paxlovid is a sequence of tablets you take to treat people within five days of illness,” he said.
Dobbs said this treatment is very effective, but it does have numerous drug reactions when taken with other medications. Molnupiravir is also an effective treatment, Dobbs said, but it is not as good as Paxlovid.
However, Molnupiravir has fewer drug interactions.
MSDH Chief Medical Officer Dan Edney, a Vicksburg physician, concurred with Dobbs on the effectiveness of both antiviral medications.
“They are very effective and help patients feel better quicker,” Edney said.
Currently, Mississippi has an adequate supply of both these medications.
“We have 2,000 treatment courses of Paxlovid and over 10,000 courses of Molnupiravir available in the state of Mississippi,” he said.
Monoclonal antibody treatments are also being used to treat those who test positive for the Omicron variant.
“As you know, the Omicron variant is not susceptible for the type of monoclonal antibodies used during the Delta surge,” Dobbs said.
But Sotrovimab is, he said. However, supplies of the medication are limited in Mississippi.
For people who are at high risk because of weakened immune systems, Evusheld, a preventive monoclonal antibody, is used, Dobbs said. This too is being underutilized.
“We have been allocated almost 4,000 doses and we have only used 135,” he said, adding, that MSDH is working hard to let providers know this (Evusheld) is available.”
All treatments, Dobbs said, are administered with medical supervision.
“We are not through the pandemic yet, Dobbs, said but we do have some tools in our toolbox. They are just being underutilized,” he said.
On the MSDH’s website, a Mississippi COVID-19 therapeutics locator has been set up to aid in finding a pharmacy in your community that can fill a prescription for oral antiviral medication.
For locals, Kroger Pharmacy can dispense oral antiviral medication if it has been prescribed by a health care provider.
Both Dobbs and Edney stressed the importance of contacting your health care provider if you have symptoms or test positive for COVID.
“There are things that can be done that can give you optimal chance for optimal health,” Dobbs said.
And for those who have not yet been vaccinated, Edney said, “Get vaccinated, get boosted and stay safe.”
Vaccines are still the best protection from viruses, he said.